147 related articles for article (PubMed ID: 36902501)
1. Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas.
Voutsadakis IA
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902501
[TBL] [Abstract][Full Text] [Related]
2. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy.
Voutsadakis IA
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32987805
[TBL] [Abstract][Full Text] [Related]
3. Amplification of 8p11.23 in cancers and the role of amplicon genes.
Voutsadakis IA
Life Sci; 2021 Jan; 264():118729. PubMed ID: 33166592
[TBL] [Abstract][Full Text] [Related]
4. 3q26 Amplifications in Cervical Squamous Carcinomas.
Voutsadakis IA
Curr Oncol; 2021 Jul; 28(4):2868-2880. PubMed ID: 34436017
[TBL] [Abstract][Full Text] [Related]
5. Elevated NSD3 histone methylation activity drives squamous cell lung cancer.
Yuan G; Flores NM; Hausmann S; Lofgren SM; Kharchenko V; Angulo-Ibanez M; Sengupta D; Lu X; Czaban I; Azhibek D; Vicent S; Fischle W; Jaremko M; Fang B; Wistuba II; Chua KF; Roth JA; Minna JD; Shao NY; Jaremko Ł; Mazur PK; Gozani O
Nature; 2021 Feb; 590(7846):504-508. PubMed ID: 33536620
[TBL] [Abstract][Full Text] [Related]
6. Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9.
Vincent-Chong VK; Anwar A; Karen-Ng LP; Cheong SC; Yang YH; Pradeep PJ; Rahman ZA; Ismail SM; Zaini ZM; Prepageran N; Kallarakkal TG; Ramanathan A; Mohayadi NA; Rosli NS; Mustafa WM; Abraham MT; Tay KK; Zain RB
PLoS One; 2013; 8(2):e54705. PubMed ID: 23405089
[TBL] [Abstract][Full Text] [Related]
7. Transforming properties of 8p11-12 amplified genes in human breast cancer.
Yang ZQ; Liu G; Bollig-Fischer A; Giroux CN; Ethier SP
Cancer Res; 2010 Nov; 70(21):8487-97. PubMed ID: 20940404
[TBL] [Abstract][Full Text] [Related]
8. Copy number changes at 8p11-12 predict adverse clinical outcome and chemo- and radiotherapy response in breast cancer.
Moelans CB; van Maldegem CMG; van der Wall E; van Diest PJ
Oncotarget; 2018 Mar; 9(24):17078-17092. PubMed ID: 29682206
[TBL] [Abstract][Full Text] [Related]
9. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH.
Ishizuka T; Tanabe C; Sakamoto H; Aoyagi K; Maekawa M; Matsukura N; Tokunaga A; Tajiri T; Yoshida T; Terada M; Sasaki H
Biochem Biophys Res Commun; 2002 Aug; 296(1):152-5. PubMed ID: 12147242
[TBL] [Abstract][Full Text] [Related]
10. Somatic copy number alterations have prognostic impact in patients with ovarian clear cell carcinoma.
Morikawa A; Hayashi T; Kobayashi M; Kato Y; Shirahige K; Itoh T; Urashima M; Okamoto A; Akiyama T
Oncol Rep; 2018 Jul; 40(1):309-318. PubMed ID: 29749539
[TBL] [Abstract][Full Text] [Related]
11. Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.
Dutt A; Ramos AH; Hammerman PS; Mermel C; Cho J; Sharifnia T; Chande A; Tanaka KE; Stransky N; Greulich H; Gray NS; Meyerson M
PLoS One; 2011; 6(6):e20351. PubMed ID: 21666749
[TBL] [Abstract][Full Text] [Related]
12. Identification of multiple DNA copy number alterations including frequent 8p11.22 amplification in conjunctival squamous cell carcinoma.
Asnaghi L; Alkatan H; Mahale A; Othman M; Alwadani S; Al-Hussain H; Jastaneiah S; Yu W; Maktabi A; Edward DP; Eberhart CG
Invest Ophthalmol Vis Sci; 2014 Dec; 55(12):8604-13. PubMed ID: 25491297
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 20q11.21 Amplifications in Colorectal Cancer.
Voutsadakis IA
Cancer Genomics Proteomics; 2021; 18(3 Suppl):487-496. PubMed ID: 33994370
[TBL] [Abstract][Full Text] [Related]
14. An mRNA Gene Expression-Based Signature to Identify FGFR1-Amplified Estrogen Receptor-Positive Breast Tumors.
Luo J; Liu S; Leung S; Gru AA; Tao Y; Hoog J; Ho J; Davies SR; Allred DC; Salavaggione AL; Snider J; Mardis ER; Nielsen TO; Ellis MJ
J Mol Diagn; 2017 Jan; 19(1):147-161. PubMed ID: 27993329
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the recurrent 8p11-12 amplicon identifies PPAPDC1B, a phosphatase protein, as a new therapeutic target in breast cancer.
Bernard-Pierrot I; Gruel N; Stransky N; Vincent-Salomon A; Reyal F; Raynal V; Vallot C; Pierron G; Radvanyi F; Delattre O
Cancer Res; 2008 Sep; 68(17):7165-75. PubMed ID: 18757432
[TBL] [Abstract][Full Text] [Related]
16. PPAPDC1B and WHSC1L1 are common drivers of the 8p11-12 amplicon, not only in breast tumors but also in pancreatic adenocarcinomas and lung tumors.
Mahmood SF; Gruel N; Nicolle R; Chapeaublanc E; Delattre O; Radvanyi F; Bernard-Pierrot I
Am J Pathol; 2013 Nov; 183(5):1634-1644. PubMed ID: 24051013
[TBL] [Abstract][Full Text] [Related]
17. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
18. Characterization of FGFR1 Locus in sqNSCLC Reveals a Broad and Heterogeneous Amplicon.
Rooney C; Geh C; Williams V; Heuckmann JM; Menon R; Schneider P; Al-Kadhimi K; Dymond M; Smith NR; Baker D; French T; Smith PD; Harrington EA; Barrett JC; Kilgour E
PLoS One; 2016; 11(2):e0149628. PubMed ID: 26905262
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma.
Parris TZ; Rönnerman EW; Engqvist H; Biermann J; Truvé K; Nemes S; Forssell-Aronsson E; Solinas G; Kovács A; Karlsson P; Helou K
Oncotarget; 2018 May; 9(35):24140-24154. PubMed ID: 29844878
[TBL] [Abstract][Full Text] [Related]
20. A Phase Ib Open-Label Multicenter Study of AZD4547 in Patients with Advanced Squamous Cell Lung Cancers.
Paik PK; Shen R; Berger MF; Ferry D; Soria JC; Mathewson A; Rooney C; Smith NR; Cullberg M; Kilgour E; Landers D; Frewer P; Brooks N; André F
Clin Cancer Res; 2017 Sep; 23(18):5366-5373. PubMed ID: 28615371
[No Abstract] [Full Text] [Related]
[Next] [New Search]
